The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Clinical biomarkers in drug discovery and development
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Health Measurement Scales: A Practical Guide to Their Development and Use
Streiner, D. L., Norman, G. R., & Cairney, J. (1989) · Cited by 9,595
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
(2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,762
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Early Lung Cancer Action Project: overall design and findings from baseline screening
Henschke, C. I., McCauley, D. I., Yankelevitz, D. F., Naidich, D. P., McGuinness, G., Miettinen, O. S., Libby, D. M., Pasmantier, M. W., Koizumi, J., Altorki, N. K., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)06093-6 · Cited by 2,508
Shipp, M. A., Ross, K. N., Tamayo, P., Weng, A. P., Kutok, J. L., Aguiar, R. C. T., Gaasenbeek, M., Angelo, M., Reich, M., Pinkus, G. S., et al. (2002) · Nature Medicine · doi:10.1038/nm0102-68 · Cited by 2,428
Health Measurement Scales: A Practical Guide to Their Development and Use
Vogelzang, J. L. (2015) · Journal of Nutrition Education and Behavior · doi:10.1016/j.jneb.2015.03.007 · Cited by 2,337
Emotion elicitation using films
Gross, J. J., & Levenson, R. W. (1995) · Cognition & Emotion · doi:10.1080/02699939508408966 · Cited by 2,179
Armstrong, B., & Doll, R. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910150411 · Cited by 2,151
Active Genes Are Tri-Methylated at K4 of Histone H3
Santos-Rosa, H., Schneider, R., Bannister, A. J., Sherriff, J., Bernstein, B. E., Emre, N. C. T., Schreiber, S. L., Mellor, J., & Kouzarides, T. (2002) · Nature · doi:10.1038/nature01080 · Cited by 2,138
Surrogate endpoints in clinical trials: Definition and operational criteria
Prentice, R. L. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080407 · Cited by 2,057
Molecular classification of cutaneous malignant melanoma by gene expression profiling
Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., Radmacher, M., Simon, R., Yakhini, Z., Ben-Dor, A., et al. (2000) · Nature · doi:10.1038/35020115 · Cited by 1,990
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,851
Surrogate End Points in Clinical Trials: Are We Being Misled?
Fleming, T. R., & DeMets, D. L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00011 · Cited by 1,651
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,641
Jacobs, L. D., Beck, R. W., Simon, J. H., Kinkel, R. P., Brownscheidle, C. M., Murray, T. J., Simonian, N. A., Slasor, P. J., & Sandrock, A. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431301 · Cited by 1,501
Computational analysis of microarray data
Quackenbush, J. (2001) · Nature Reviews Genetics · doi:10.1038/35076576 · Cited by 1,471
A gene expression database for the molecular pharmacology of cancer
Scherf, U., Ross, D. T., Waltham, M., Smith, L. H., Lee, J. K., Tanabe, L., Kohn, K. W., Reinhold, W. C., Myers, T. G., Andrews, D. T., et al. (2000) · Nature Genetics · doi:10.1038/73439 · Cited by 1,450
Rudd, J. H. F., Warburton, E. A., Fryer, T. D., Jones, H. A., Clark, J. C., Antoun, N., Johnström, P., Davenport, A. P., Kirkpatrick, P. J., Arch, B. N., et al. (2002) · Circulation · doi:10.1161/01.cir.0000020548.60110.76 · Cited by 1,226
Drusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208
Imaging proliferation in vivo with [F-18]FLT and positron emission tomography
Shields, A. F., Grierson, J. R., Dohmen, B. M., Machulla, H.-J., Stayanoff, J. C., Lawhorn-Crews, J. M., Obradovich, J. E., Muzik, O., & Mangner, T. J. (1998) · Nature Medicine · doi:10.1038/3337 · Cited by 1,204
Sheline, Y. I., Barch, D. M., Donnelly, J. M., Ollinger, J. M., Snyder, A. Z., & Mintun, M. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01263-x · Cited by 1,191
Dynamics of Gray Matter Loss in Alzheimer's Disease
Thompson, P. M., Hayashi, K. M., de Zubicaray, G., Janke, A. L., Rose, S. E., Semple, J., Herman, D., Hong, M. S., Dittmer, S. S., Doddrell, D. M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00994.2003 · Cited by 1,132
Brindle, J. T., Antti, H., Holmes, E., Tranter, G., Nicholson, J. K., Bethell, H. W. L., Clarke, S., Schofield, P. M., McKilligin, E., Mosedale, D. E., et al. (2002) · Nature Medicine · doi:10.1038/nm1202-802 · Cited by 1,029
Pitfalls in the Use of DNA Microarray Data for Diagnostic and Prognostic Classification
Simon, R., Radmacher, M. D., Dobbin, K., & McShane, L. M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.1.14 · Cited by 1,006
Drysdale, C. M., McGraw, D. W., Stack, C. B., Stephens, J. C., Judson, R. S., Nandabalan, K., Arnold, K., Ruano, G., & Liggett, S. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10483 · Cited by 964
Nieman, K., Cademartiri, F., Lemos, P. A., Raaijmakers, R., Pattynama, P. M. T., & de Feyter, P. J. (2002) · Circulation · doi:10.1161/01.cir.0000037222.58317.3d · Cited by 956
Silverman, D. H. S., Small, G. W., Chang, C. Y., Lu, C. S., de Aburto, M. A. K., Chen, W., Czernin, J., Rapoport, S. I., Pietrini, P., Alexander, G. E., et al. (2001) · JAMA · doi:10.1001/jama.286.17.2120 · Cited by 951
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD
Jack, C. R., Petersen, R. C., Xu, Y., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Tangalos, E. G., & Kokmen, E. (2000) · Neurology · doi:10.1212/wnl.55.4.484 · Cited by 937
Exacerbation of Pain by Anxiety Is Associated with Activity in a Hippocampal Network
Ploghaus, A., Narain, C., Beckmann, C. F., Clare, S., Bantick, S., Wise, R., Matthews, P. M., Rawlins, J. N. P., & Tracey, I. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09896.2001 · Cited by 822 · cited 1×
“In pain research, fMRI-based psychophysical studies can assess brain activation by pain, its anticipation and modulation by attentio”
BackgroundMolecular imaging in drug discovery and development
Rudin, M., & Weissleder, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1007 · Cited by 815
Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful?
Duffy, M. J. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.4.624 · Cited by 794
Estrogen in the Prevention of Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Hodis, H. N., Mack, W. J., Lobo, R. A., Shoupe, D., Sevanian, A., Mahrer, P. R., Selzer, R. H., Liu, C.-R., Liu, C.-H., Azen, S. P., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00005 · Cited by 687
Sunderland, T., Linker, G., Mirza, N., Putnam, K. T., Friedman, D. L., Kimmel, L. H., Bergeson, J., Manetti, G. J., Zimmermann, M., Tang, B., et al. (2003) · JAMA · doi:10.1001/jama.289.16.2094 · Cited by 656
Presymptomatic hippocampal atrophy in Alzheimer's disease: A longitudinal MRI study
Fox, N. C., Warrington, E. K., Freeborough, P. A., Hartikainen, P., Kennedy, A. M., Stevens, J. M., & Rossor, M. N. (1996) · Brain · doi:10.1093/brain/119.6.2001 · Cited by 656
Wang, W., Zhou, H., Lin, H., Roy, S., Shaler, T. A., Hill, L. R., Norton, S., Kumar, P., Anderle, M., & Becker, C. H. (2003) · Analytical Chemistry · doi:10.1021/ac026468x · Cited by 653
de Leon, M. J., Convit, A., Wolf, O. T., Tarshish, C. Y., DeSanti, S., Rusinek, H., Tsui, W., Kandil, E., Scherer, A. J., Roche, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191044198 · Cited by 629
Small Pulmonary Nodules: Volumetrically Determined Growth Rates Based on CT Evaluation
Yankelevitz, D. F., Reeves, A. P., Kostis, W. J., Zhao, B., & Henschke, C. I. (2000) · Radiology · doi:10.1148/radiology.217.1.r00oc33251 · Cited by 579
Delineating the Genetic Basis of Systemic Lupus Erythematosus
Wakeland, E. K., Liu, K., Graham, R. R., & Behrens, T. W. (2001) · Immunity · doi:10.1016/s1074-7613(01)00201-1 · Cited by 556
Clinical proteomics: translating benchside promise into bedside reality
Petricoin, E. F., Zoon, K. C., Kohn, E. C., Barrett, J. C., & Liotta, L. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd891 · Cited by 550
Neuhold, L. A., Killar, L., Zhao, W., Sung, M.-L. A., Warner, L., Kulik, J., Turner, J., Wu, W., Billinghurst, C., Meijers, T., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10564 · Cited by 540
Wintermark, M., Reichhart, M., Thiran, J., Maeder, P., Chalaron, M., Schnyder, P., Bogousslavsky, J., & Meuli, R. (2002) · Annals of Neurology · doi:10.1002/ana.10136 · Cited by 530
ESTIMATING THE PROPORTION OF TREATMENT EFFECT EXPLAINED BY A SURROGATE MARKER
LIN, D. Y., FLEMING, T. R., & DE GRUTTOLA, V. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970715)16:13<1515::aid-sim572>3.0.co;2-1 · Cited by 520
Morris, J. C., & Price, J. L. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:101 · Cited by 513
Morrish, P. K., Rakshi, J. S., Bailey, D. L., Sawle, G. V., & Brooks, D. J. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.3.314 · Cited by 510
Huestis, M. A., Gorelick, D. A., Heishman, S. J., Preston, K. L., Nelson, R. A., Moolchan, E. T., & Frank, R. A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.322 · Cited by 481
Self-citationDissociable prefrontal brain systems for attention and emotion
Yamasaki, H., LaBar, K. S., & McCarthy, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182176499 · Cited by 477
Corti, R., Fuster, V., Fayad, Z. A., Worthley, S. G., Helft, G., Smith, D., Weinberger, J., Wentzel, J., Mizsei, G., Mercuri, M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000041255.88750.f0 · Cited by 470
Lesko, L., & Atkinson, A. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.347 · Cited by 465
Yuan, C., Zhang, S.-X., Polissar, N. L., Echelard, D., Ortiz, G., Davis, J. W., Ellington, E., Ferguson, M. S., & Hatsukami, T. S. (2002) · Circulation · doi:10.1161/hc0202.102121 · Cited by 454
Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials
De Gruttola, V. G., Clax, P., DeMets, D. L., Downing, G. J., Ellenberg, S. S., Friedman, L., Gail, M. H., Prentice, R., Wittes, J., & Zeger, S. L. (2001) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00153-2 · Cited by 427
Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
Buyse, M., & Molenberghs, G. (1998) · Biometrics · doi:10.2307/2533853 · Cited by 425
Metabolic Flare: Indicator of Hormone Responsiveness in Advanced Breast Cancer
Mortimer, J. E., Dehdashti, F., Siegel, B. A., Trinkaus, K., Katzenellenbogen, J. A., & Welch, M. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2797 · Cited by 410
Probing picture perception: Activation and emotion
Cuthbert, B. N., Bradleym, M. M., & Lang, P. J. (1996) · Psychophysiology · doi:10.1111/j.1469-8986.1996.tb02114.x · Cited by 403
Pantoja, T., & Letelier, L. M. (2003) · Revista médica de Chile · doi:10.4067/s0034-98872003001000017 · Cited by 386
Genetics and Pathophysiology of Human Obesity
Cummings, D. E., & Schwartz, M. W. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152403 · Cited by 372
Meta-analysis for the evaluation of potential surrogate markers
Daniels, M. J., & Hughes, M. D. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970915)16:17<1965::aid-sim630>3.0.co;2-m · Cited by 362
Fox, N. C., Cousens, S., Scahill, R., Harvey, R. J., & Rossor, M. N. (2000) · Archives of Neurology · doi:10.1001/archneur.57.3.339 · Cited by 360
Are Surrogate Markers Adequate to Assess Cardiovascular Disease Drugs?
Temple, R. (1999) · JAMA · doi:10.1001/jama.282.8.790 · Cited by 337
Stefanadis, C., Diamantopoulos, L., Vlachopoulos, C., Tsiamis, E., Dernellis, J., Toutouzas, K., Stefanadi, E., & Toutouzas, P. (1999) · Circulation · doi:10.1161/01.cir.99.15.1965 · Cited by 331
Shotgun Proteomics and Biomarker Discovery
McDonald, W. H., & Yates, J. R. (2002) · Disease Markers · doi:10.1155/2002/505397 · Cited by 314
Picture media and emotion: Effects of a sustained affective context
BRADLEY, M. M., CUTHBERT, B. N., & LANG, P. J. (1996) · Psychophysiology · doi:10.1111/j.1469-8986.1996.tb02362.x · Cited by 312
MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD
Jack, C. R., Slomkowski, M., Gracon, S., Hoover, T. M., Felmlee, J. P., Stewart, K., Xu, Y., Shiung, M., O’Brien, P. C., Cha, R., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000042480.86872.03 · Cited by 297
Use of Positron Emission Tomography in Animal Research
Cherry, S. R., & Gambhir, S. S. (2001) · ILAR Journal · doi:10.1093/ilar.42.3.219 · Cited by 284
[The Scandinavian Simvastatin Survival Study (4S)].
Gram, J. (1995) · PubMed · Cited by 283
Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects
Dresser, G. K., Schwarz, U. I., Wilkinson, G. R., & Kim, R. B. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2003.10 · Cited by 261
Van den Abbeele, A. D., & Badawi, R. D. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80604-9 · Cited by 257
Biological markers for therapeutic trials in Alzheimer’s disease
Frank, R. A., Galasko, D., Hampel, H., Hardy, J., de Leon, M. J., Mehta, P. D., Rogers, J., Siemers, E., & Trojanowski, J. Q. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00002-2 · Cited by 252
Self-citationHuman Hepatic Flavin-Containing Monooxygenases 1 (FMO1) and 3 (FMO3) Developmental Expression
Koukouritaki, S. B., Simpson, P., Yeung, C. K., Rettie, A. E., & Hines, R. N. (2002) · Pediatric Research · doi:10.1203/00006450-200202000-00018 · Cited by 245
A combined PET/CT scanner: the path to true image fusion
Townsend, D. W., & Beyer, T. (2002) · The British Journal of Radiology · doi:10.1259/bjr.75.suppl_9.750024 · Cited by 241
Kitagawa, H., Takenouchi, T., Azuma, R., Wesnes, K. A., Kramer, W. G., Clody, D. E., & Burnett, A. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300028 · Cited by 238
Delayed ontogenesis of CYP1A2 in the human liver
Sonnier, M., & Cresteil, T. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2510893.x · Cited by 231
Zhuang, Z.-P., Kung, M.-P., Wilson, A., Lee, C.-W., Plössl, K., Hou, C., Holtzman, D. M., & Kung, H. F. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020351j · Cited by 215
Wandel, C., Kim, R., Wood, M., & Wood, A. (2002) · Anesthesiology · doi:10.1097/00000542-200204000-00019 · Cited by 215
Wise, R. (2002) · NeuroImage · doi:10.1006/nimg.2002.1146 · Cited by 192
Grillon, C., Cordova, J., Levine, L. R., & Morgan, III (2003) · Psychopharmacology · doi:10.1007/s00213-003-1444-8 · Cited by 185
Atrophy rates of entorhinal cortex in AD and normal aging
Du, A. T., Schuff, N., Zhu, X. P., Jagust, W. J., Miller, B. L., Reed, B. R., Kramer, J. H., Mungas, D., Yaffe, K., Chui, H. C., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000044400.11317.ec · Cited by 184
den Broeder, A. A., Joosten, L. A. B., Saxne, T., Heinegård, D., Fenner, H., Miltenburg, A. M. M., Frasa, W. L. H., van Tits, L. J., Buurman, W. A., van Riel, P. L. C. M., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.4.311 · Cited by 161
Imaging substance P receptors (NK1) in the living human brain using positron emission tomography.
Hargreaves, R. J. (2002) · PubMed · Cited by 153
Self-citationBrain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial
Study, T. A. D. C., Grundman, M., Sencakova, D., Jack, C. R., Petersen, R. C., Kim, H. T., Schultz, A. N., Weiner, M., DeCarli, C. S., DeKosky, S. T., et al. (2002) · Journal of Molecular Neuroscience · doi:10.1007/s12031-002-0006-6 · Cited by 153
Lesko, L. J., Rowland, M., Peck, C. C., & Blaschke, T. F. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022009530 · Cited by 152
Bossuyt, P. M., & Reitsma, J. B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12122-8 · Cited by 149
On meta-analytic assessment of surrogate outcomes
Gail, M. H. (2000) · Biostatistics · doi:10.1093/biostatistics/1.3.231 · Cited by 149
Szalai, A. J., McCrory, M. A., Cooper, G. S., Wu, J., & Kimberly, R. P. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363820 · Cited by 145
MRI and Characterization of Atherosclerotic Plaque: Emerging Applications and Molecular Imaging
Choudhury, R. P., Fuster, V., Badimón, J. J., Fisher, E. A. A., & Fayad, Z. A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000019735.54479.2f · Cited by 143
Crum, W. R., Scahill, R. I., & Fox, N. C. (2001) · NeuroImage · doi:10.1006/nimg.2001.0744 · Cited by 139
Dual-modality PET/CT tomography for clinical oncology.
Beyer, T., Townsend, D. W., & Blodgett, T. M. (2002) · PubMed · Cited by 137
Selective serotonin reuptake inhibitors and neuroendocrine function
Raap, D. K., & de Kar, L. D. V. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00169-1 · Cited by 125
Nissen, S. E. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02217-8 · Cited by 125
Crying threshold and intensity in major depressive disorder
Rottenberg, J., Gross, J. J., Wilhelm, F. H., Najmi, S., & Gotlib, I. H. (2002) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.111.2.302 · Cited by 122
Whole-Body Positron Emission Tomography—CT: Optimized CT Using Oral and IV Contrast Materials
Antoch, G., Freudenberg, L. S., Stattaus, J., Jentzen, W., Müeller, S., Debatin, J. F., & Bockisch, A. (2002) · American Journal of Roentgenology · doi:10.2214/ajr.179.6.1791555 · Cited by 117
van der Wal, A. C., Piek, J. J., de Boer, O. J., Koch, K. T., Teeling, P., van der Loos, C. M., & Becker, A. E. (1998) · Heart · doi:10.1136/hrt.80.1.14 · Cited by 117
Biomarkers for the effects of benzodiazepines in healthy volunteers
de Visser, S. J., Post, J. P. V. D., de Waal, P. P., Cornet, F., Cohen, A. F., & van Gerven, J. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.t01-10-01714.x · Cited by 115
In vivo imaging of neuroinflammation
Cagnin, A., Gerhard, A., & Banati, R. B. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00107-4 · Cited by 112
Venkatakrishnan, K., Moltke, L. L., & Greenblatt, D. J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29543-4 · Cited by 112
Gupta, N. C., Graeber, G. M., Rogers, J., et al. (1999) · Annals of Surgery · doi:10.1097/00000658-199902000-00018 · Cited by 111
Conrad, S., Kauffmann, H.-M., Ito, K., Leslie, E. M., Deeley, R. G., Schrenk, D., & Cole, S. P. C. (2002) · Pharmacogenetics · doi:10.1097/00008571-200206000-00008 · Cited by 110
An investigation of the range of cognitive impairments induced by scopolamine 0·6 mg s.c
Wesnes, K. A., Simpson, P., & Kidd, A. G. (1988) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470030106 · Cited by 109
The Role of PET in Localization of Neuroendocrine and Adrenocortical Tumors
Eriksson, B. K., Bergström, M., Sundin, A., Juhlin, C., Örlefors, H., Öberg, K., & Långström, B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04422.x · Cited by 109
Herman, E. H., Zhang, J., Rifai, N., Lipshultz, S. E., Hasinoff, B. B., Chadwick, D. P., Knapton, A. D., Chai, J., & Ferrans, V. J. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100348 · Cited by 106
Hopper, K. D., Singapuri, K., & Finkel, A. (2000) · Radiology · doi:10.1148/radiology.215.1.r00ap1727 · Cited by 105
Does Inflammation Cut to the Heart of the Matter?
Taubes, G. (2002) · Science · doi:10.1126/science.296.5566.242 · Cited by 103
Early lung cancer action project
Henschke, C. I. (2000) · Cancer · Cited by 96
Drug metabolism and pharmacokinetics in drug discovery.
Roberts, S. A. (2003) · PubMed · Cited by 95
Rolan, P. E. (1997) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1997.t01-1-00583.x · Cited by 95
Detection of Locoregional and Distant Recurrences in Breast Cancer Patients by Using FDG PET
Eubank, W. B., Mankoff, D. A., Vesselle, H. J., Eary, J. F., Schubert, E. K., Dunnwald, L. K., Lindsley, S. K., Gralow, J. R., Austin-Seymour, M., Ellis, G. K., et al. (2002) · Radiographics · doi:10.1148/radiographics.22.1.g02ja055 · Cited by 91
PHARMACOGENETICS AND PHARMACOGENOMICS
Leeder, J. S. (2001) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70338-2 · Cited by 89
Imaging of the disease process
PETERFY, C. G. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200209000-00020 · Cited by 88
Mankoff, D. A., Dehdashti, F., & Shields, A. F. (2000) · Neoplasia · doi:10.1038/sj.neo.7900075 · Cited by 87
Colburn, W. A. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/009127000004001212 · Cited by 86
Case-Control Association Studies in Pharmacogenetics
Weiss, S. T., Silverman, E. K., & Palmer, L. J. (2001) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500050 · Cited by 64
MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients
Sormani, M. P., Bruzzi, P., Comı, G., & Filippi, M. (2002) · Neurology · doi:10.1212/wnl.58.3.417 · Cited by 61
Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., & Barbanoj, M. (2001) · Psychopharmacology · doi:10.1007/s002130100816 · Cited by 60
Kiberstis, P. A., & Roberts, L. J. (2002) · Science · doi:10.1126/science.296.5568.685 · Cited by 59
In vitro metabolic interaction studies: Experience of the Food and Drug Administration
Yuan, R., PARMELEE, T., Balian, J. D., Uppoor, R. S., Ajayi, F., Burnett, A. L. “., Lesko, L. L., & Marroum, P. J. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70048-2 · Cited by 48
Delivery of High‐Quality Biomarker Assays
Swanson, B. N. (2002) · Disease Markers · doi:10.1155/2002/212987 · Cited by 47
Neuroendocrine responses to laboratory panic: Cognitive intervention in the doxapram model
Abelson, J. L., Weg, J. G., Nesse, R. M., & Curtis, G. C. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(96)00005-4 · Cited by 40
Lesko, L. J., Rowland, M., Peck, C. C., Blaschke, T. F., Breimer, D., de Jong, H. J., Grahnen, A., Kuhlmann, J. J., & Stewart, B. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00092-0 · Cited by 37
Tanaka, C., Kawai, R., & Rowland, M. (1999) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1023/a:1020978509566 · Cited by 35
QT Interval Prolongation as a Biomarker for Torsades de Pointes and Sudden Death in Drug Development
Sides, G. D. (2002) · Disease Markers · doi:10.1155/2002/482953 · Cited by 29
Biomarker discovery by comprehensive phenotyping for autoimmune diseases
Kantor, A. B., Wang, W., Lin, H., Govindarajan, H., Anderle, M., Perrone, A., & Becker, C. H. (2004) · Clinical Immunology · doi:10.1016/j.clim.2003.12.011 · Cited by 28
A simple simulated public speaking test for evaluating anxiolytic drugs.
Fs, G., Cl, K., Gus, G., Hs, F., Mc, D.-V., Cl, D.-P., Ribeiro, A. M., Cc, T., & Wannmacher, L. (1989) · PubMed · Cited by 27
Alonso, A., Geys, H., Molenberghs, G., & Vangeneugden, T. (2002) · Journal of Biopharmaceutical Statistics · doi:10.1081/bip-120015741 · Cited by 22
Bayesian estimation of the proportion of treatment effect captured by a surrogate marker
Cowles, M. K. (2002) · Statistics in Medicine · doi:10.1002/sim.1057 · Cited by 20
Comprehensive phenotyping and biological marker discovery
Kantor, A. B. (2002) · Disease Markers · doi:10.1155/2002/178798 · Cited by 16
Carbon dioxide test as an additional clinical measure of treatment response in panic disorder
Valença, A. M., Nardi, A. E., Nascimento, I., Zin, W. A., & Versiani, M. (2002) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2002000300003 · Cited by 13
Effects of intravenous diazepam pretreatment on lactate-induced panic
Liebowitz, M. R., Coplan, J. D., Martínez, J. A. B., Fyer, A. J., Dillon, D. J., Campeas, R. B., Davies, S. O., Gorman, J. M., & Klein, D. F. (1995) · Psychiatry Research · doi:10.1016/0165-1781(95)02530-a · Cited by 13
Chin, B. B. (2002) · Molecular Imaging and Biology · doi:10.1016/s1536-1632(02)00085-9 · Cited by 5
Trojanowski, J. Q. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3210 · Cited by 4
Targeting Alzheimer's disease: Is there a light at the end of the tunnel?
Gurwitz, D. (2002) · Drug Development Research · doi:10.1002/ddr.10059 · Cited by 4
Ho (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200110)44:10 · Cited by 3
The Use of Imaging as Biomarkers in Drug Development: Regulatory Issues Worldwide
Katz, R., Wagner, H. N., Fauntleroy, M., et al. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/009127001773744288 · Cited by 2
Cited by
Fass, L. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.04.001 · Cited by 822
Multiplexed protein measurement: technologies and applications of protein and antibody arrays
Kingsmore, S. F. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2006 · Cited by 715
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Hampel, H., Frank, R., Broich, K., Teipel, S. J., Katz, R. G., Hardy, J., Herholz, K., Bokde, A. L. W., Jessen, F., Hoessler, Y. C., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3115 · Cited by 631
Self-citationWearable chemical sensors for biomarker discovery in the omics era
Sempionatto, J. R., Lasalde-Ramírez, J. A., Mahato, K., Wang, J., & Gao, W. (2022) · Nature Reviews Chemistry · doi:10.1038/s41570-022-00439-w · Cited by 613
New approaches to molecular cancer therapeutics
Collins, I., & Workman, P. (2006) · Nature Chemical Biology · doi:10.1038/nchembio840 · Cited by 391
Metadata
- Authors
- Frank, R., & Hargreaves, R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-07
- Volume
- 2
- Issue
- 7
- Pages
- 566-580
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2000980666
- Cited by
- 794
- References
- 142
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.